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Phospholipid environment alters hormone-sensitivity of the
purified insulin receptor kinase
Robert E. LEWIS and Michael P. CZECH
Department of Biochemistry, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01605,
U.S.A.
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Insulin receptor kinase, affinity-purified by adsorption and elution from immobilized insulin, is stimulated
2-3-fold by insulin in detergent solution. Reconstitution of the receptor kinase into leaky vesicles containing
phosphatidylcholine and phosphatidylethanolamine (1: 1, w/w) by detergent removal on Sephadex G-50
results in the complete loss of receptor kinase sensitivity to activation by insulin. Insulin receptors in these
vesicles also exhibit an increase in their apparent affinity for 1251I-insulin (Kd= 0.12 nm versus 0.76 nM).
Inclusion of 8.3-16.7% phosphatidylserine into the reconstituted vesicles restores 40-50% of the insulin-
sensitivity to the receptor kinase. An elevated apparent affinity for 1251-insulin of insulin receptors in vesicles
containing phosphatidylcholine and phosphatidylethanolamine is also restored to the value observed in
detergent solution by the inclusion of phosphatidylserine in the reconstituted system. The effect of
phosphatidylserine on insulin receptor kinase appears specific, because cholesterol, phosphatidylinositol and
phosphatidic acid are all unable to restore insulin-sensitivity to the receptor kinase. Autophosphorylation
sites on the insulin receptor as analysed by h.p.l.c. of tryptic 32P-labelled receptor phosphopeptides are not
different for insulin receptors autophosphorylated in detergent solution or for the reconstituted vesicles in
the presence or absence of phosphatidylserine. These data indicate that the phospholipid environment of
insulin receptors can modulate its binding and kinase activity, and phosphatidylserine acts to restore insulin-
sensitivity to the receptor kinase incorporated into phosphatidylcholine/phosphatidylethanolamine vesicles.
INTRODUCTION
The insulin receptor is a transmembrane protein,
composed of two a and two , subunits, responsible for
transducing information from the hormone insulin to the
cell interior (Czech, 1985; Jacobs & Cuatrecasas, 1983).
Examination of the deduced sequence of the human
placental insulin receptor from the isolated cDNA
demonstrated regions of marked homology between the
insulin-receptor f, subunit and the family of src-related
tyrosine kinases (Ullrich et al., 1985; Ebina et al., 1985).
The ft subunits span the membrane, and have been
shown to be phosphorylated on serine and tyrosine
residues in intact cells (Kasuga et al., 1982a,b; Haring
et al., 1982), and to undergo insulin-dependent
phosphorylation (Petruzzelli et al., 1982; Avruch et al.,
1982; Roth & Cassel, 1983; Zick et al., 1983). Phos-
phorylation of the receptor activates the insulin-sensitive
kinase (Rosen et al., 1983; Yu & Czech, 1984). Kinetic
studies with different peptide substrates have suggested
that the specificity of the insulin-receptor-associated
kinase is similar to the src-related kinases and to the
epidermal-growth-factor receptor kinase (Stadtmauer &
Rosen, 1983; Pike et al., 1984).
Factors which regulate the insulin receptor kinase
activity are of major interest because the kinase may be
intimately involved in one or more receptor functions.
The lipid environment has been suggested as a modulator
of insulin receptor activity. Insulin receptors reconsti-
tuted in crude form from turkey erythrocytes into
liposomes were found to have a higher affinity for insulin
in a more saturated lipid environment (Gould et al.,
1982). Additionally, increasing the degree ofunsaturation
of membrane phospholipids resulted in both an increase
in the available number of binding sites and a decrease in
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the affinity of these sites in Friend erythroleukaemia cells
(Ginsberg et al., 1981). Effects of lipid composition on
insulin receptor kinase activity have not been reported.
Sweet et al. (1985) previously reconstituted purified
insulin receptors in permanent phospholipid vesicles,
with the binding site exposed on the outer surface of the
liposomes. The aim of the present investigation was to
evaluate the effects of lipids on the insulin receptor
kinase by using a highly purified receptor preparation
and a well-defined lipid environment. We have utilized
an affinity-purification protocol to purify kinase-active
insulin receptor from human placenta. The purified
receptor has been reconstituted into liposomes of defined
composition. We demonstrate in this paper that: (1)
insulin receptors reconstituted into phosphatidylcholine/
phosphatidylethanolamine vesicles lose insulin-sensitive
kinase activity; (2) inclusion of phosphatidylserine in
phosphatidylcholine/phosphatidylethanolamine vesicles
restores insulin-sensitivity to the reconstituted insulin
receptor; (3) phosphatidylinositol, phosphatidic acid
and cholesterol do not restore insulin-sensitivity to
reconstituted insulin receptors; (4) receptor reconstitu-
tion into phosphatidylcholine/phosphatidylethanol-
amine vesicles correlates with an increased high-affinity
binding of insulin which is not observed in
phosphatidylcholine/phosphatidylethanolamine/
phosphatidylserine vesicles.
EXPERIMENTAL
Materials
Wheat-germ-agglutinin-Sepharose was from
Pharmacia (Piscataway, NJ, U.S.A.). Affigel and
Enzymobeads were from Bio-Rad (Rockville Centre,
R. E. Lewis and M. P. Czech
NY, U.S.A.). All phospholipids were from Supelco
(Bellefonte, PA, U.S.A.). Cholesterol, N-acetyl-D-glucos-
amine, 4-phosphotyrosine, phosphothreonine and phos-
phoserine were from Sigma (St. Louis, MO, U.S.A.).
Histone 2B was obtained from Worthington (Melvern,
PA, U.S.A.). [3H]phosphatidylcholine was purchased
from New England Nuclear (Boston, MA, U.S.A.).
Nal'25I and [y-32P]ATP were purchased from Amersham
(Arlington Heights, IL, U.S.A.). Trifluoroacetic acid was
purchased from Pierce (Rockford, IL, U.S.A.). Propan-
1-ol was from Burdick and Jackson Laboratories
(Muskegon, MI, U.S.A.). Polygram gel 300 chroma-
tography plates were purchased from Brinkmann
Instruments (Westbury, NY, U.S.A). Pig insulin was a
gift from Dr. R. Chance, Eli Lilly Co. (Indianapolis, IN,
U.S.A.).
Solubilization and purification of insulin receptors
Crude plasma membranes were prepared from human
placenta by the method of Harrison & Itin (1980).
Insulin receptor was purified by the method of Fujita-
Yamaguchi et al. (1983). Membranes were solubilized
in 50 mM-Tris/ 1 mM-phenylmethanesulphonyl fluoride/
10 /LM-leupeptin/1 % Triton X-100, pH 7.6, by end-over-
end mixing for 1 h at 4 'C. The membrane concentration
at solubilization was 8-10 mg/ml. Solubilized mem-
branes were centrifuged for 1 h at 100000 g in a Beckman
50.2 rotor. The resulting supernatant was diluted 10-
fold with 50 mM-Tris/0. 1 mM-phenylmethanesulphonyl
fluoride/ 10 ,sM-leupeptin/0.1 % Triton X-100 (buffer A)
containing 10 mM-MgCl2, pH 7.6. The diluted super-
natant (250-500 ml) was passed over 20 ml of wheat-
germ-agglutinin-Sepharose and recycled over the
column at 4 'C overnight. After washing the column
with 10 column vol. of buffer A plus 10 mM-MgCl2,
pH 7.6, the glycoproteins bound to the matrix were
eluted with 0.3 M-N-acetyl-D-glucosamine. The resulting
eluate was adjusted to 1 M with NaCl before being
applied to 10 ml of insulin-Affigel cross-linked at a ratio
of approx. 0.8 mg of insulin/ml of Affigel. The wheat-
germ eluate was passed twice over the insulin-Affigel at
room temperature. The insulin-Affigel affinity column
was then washed with 10 column vol. of 50 mM-Tris/1 M-
NaCl/0.1% Triton X-100, pH 7.6. The column was
eluted with 50 mM-sodium acetate/0.5 M-NaCl/0.1 %
Triton X-100, pH 5.5. Eluted receptor was collected in
10 ml fractions in tubes containing 5 ml of 0.5 M-Tris/
HCI, pH 7.6. The peak binding fraction of purified
receptor (fraction 2) was concentrated 3-6-fold on an
Amicon concentrator with a YM30 membrane.
Insulin receptor reconstitution
The purified receptor was reconstituted by the method
of Brunner et al. (1976) as modified by Shanahan &
Czech (1977) for the glucose transporter. The con-
centrated purified receptor (0.5 ml) was added to a total
of 12 mg of the indicated phospholipids, which had been
previously evaporated to dryness under N2 and freeze-
dried overnight. Then 10 mg of sodium cholate was
added to the receptor/lipid mixture to make the final
cholate concentration 2 %. The mixture was vortex-
mixed and sonicated in a bath sonicator until clear. After
sonication, the solution was applied to an 18 cm x 0.7 cm
Sephadex G-50 column pre-equilibrated with 10 mm-
Tris/l00 mM-NaCI/2 mM-MgSO4, pH 7.6, at 4 °C, and
0.5 ml fractions were collected. Vesicles were collected in
the column void volume. Peak vesicle-containing frac-
tions were monitored by the A280 and the addition of
tracer [3H]phosphatidylcholine (60 Ci/nmol) to some
preparations. Vesicle size was calculated from measure-
ment of vesicle diffusion coefficients as determined by
photon-correlation spectroscopy in a Coulter model N4
Submicron Particle Analyser with size-distribution pro-
cessor.
Binding analysis
125I-insulin was prepared to a specific radioactivity of
130-200 Ci/g by the lactoperoxidase method using
Enzymobeads. Specific binding to soluble and reconsti-
tuted insulin receptor was assessed by poly(ethylene
glycol) precipitation and filtration. Briefly, insulin recep-
tor was incubated with 125I-insulin in a total volume of
0.5 ml of 50 mM-Tris/ 1 % bovine serum albumin, pH 7.6,
at 22 'C. Non-specific binding was determined by the
addition of 100 nm unlabelled pig insulin to identical
tubes. Precipitation of the labelled ligand-receptor
complex was facilitated by rapid addition of 200,l of
ice-cold y-globulin (2.5 mg/ml) in 50 mM-Tris, pH 7.6,
and 0.5 ml of ice-cold 25% (v/v) poly(ethylene glycol) in
50 mM-Tris, pH 7.6. The mixture was quickly vortex-
mixed and placed in an ice bath for 10 min. Filtration
was performed on a Gilman filtration apparatus with
0.45 ,um Millipore HA filters presoaked in 1 % bovine
serum albumin. Each filter was rapidly washed with
2 x 2.5 ml of ice-cold 8% poly(ethylene glycol)/0.025%
Triton X-100 in 50 mM-Tris, pH 7.6. Radioactivity
bound to filters was determined in a Beckman Gamma
5500 counter.
Receptor kinase assays
Soluble and reconstituted insulin receptors were
incubated with 50 mM-Tris, pH 7.6, containing 10 mM-
MgCl2, 3 mM-MnClI, 1 mM-dithiothreitol and in the
presence or absence of 100 nM-insulin. Phosphorylation
was initiated by addition of [y-32P]ATP (final concn.
S M). In some reactions, histone 2B (0.3 mg/ml) was
added to the reaction mixture. The final volume of each
reaction was 100,u. The reaction was terminated by
adding an equal volume of electrophoresis sample buffer
containing 62.5 mM-Tris, 20% (v/v) glycerol, 10% (w/v)
SDS and 100 mM-dithiothreitol, pH 6.8. All samples
were boiled for 5 min. Samples containing histone were
electrophoresed on 6-16 %-polyacrylamide gels. After
electrophoresis the gels were stained, destained, dried
and autoradiographed with Kodak X-Omat film and
enhancing screens.
Tryptic-peptide mapping by h.p.l.c.
Adequate identification of phosphorylated peptide
fragments required increased radioactive labelling of the
insulin receptor. Consequently, the specific radioactivity
of [y-32P]ATP used for these experiments was raised to
1 mCi/nmol. After phosphorylation, the sample was
alkylated and reduced as follows: 100,1 of phosphoryl-
ated insulin receptor was combined with 110 ,ul of
28 mM-dithiothreitol in 10% SDS and incubated at
80 'C for 15 min. The samples were cooled to 22 'C, and
54,1 of 800 mM-iodoacetamide in 0.25 M-Tris, pH 8.8,
was added for 10 min. Next 68 ,ul of 25% (v/v)
mercaptoethanol in 75 % glycerol was added, and the
mixture was incubated at 60 °C for a further 5 min. After
reduction, 6 ,ul of 0.025% Bromophenol Blue was added
1987
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to each sample, and the samples were electrophoresed on
a 7 %-polyacrylamide gel (two lanes/sample). The 32P-
labelled , subunit of the insulin receptor was localized
after electrophoresis by autoradiography of the unfixed
gel. Gel pieces corresponding to the 32P-labelled bands
(1 cm x 2.5 cm) were excised and washed twice at 22 °C
for 45 min with 50 ml of 50 mM-NH4HCO3 buffer. Each
gel piece was then cut into five equal pieces and incubated
with 4 ml ofNH4HCO3 containing 50 ,ug of tosylphenyl-
alanylchloromethane-treated trypsin/ml and incubated
at 37 'C. A second addition of trypsin was made 15 h
later, and incubation at 37 'C was continued for a
further 10 h. The digestion product was removed and
freeze-dried overnight. The dried digest was resuspended
in 0.5 ml of 1 % trifluoroacetic acid and applied to a
Waters h.p.l.c. reverse-phase ,uBondapak C-18 column
pre-equilibrated in 0.1% trifluoroacetic acid. The 32p_
labelled tryptic peptides were eluted from the column
with a linear 0-40% propan-1-ol gradient at 0.5 ml/min.
Radioactivity was collected in 1 min fractions and
quantified by Cerenkov counting.
RESULTS
Characterization of affinity-purified insulin receptor
The two-step affinity-purification method yields highly
purified insulin receptor essentially identical with that
prepared by Fujita-Yamaguchi et al. (1983). Electro-
phoresis of the receptor under non-reduced conditions
yields 350 kDa, 320 kDa and 290 kDa silver-stained
bands, whereas electrophoresis in the presence of
reductant yields 125 kDa and 90 kDa bands (results not
shown). The preparation appears homogeneous by silver
staining, as no other silver-stained constituents are
observed. The wheat-germ-agglutinin-agarose affinity
column (15 ml) typically provides 90-100 % recovery of
insulin receptor (assessed by 1251-insulin binding) from
detergent-solubilized placental membranes. Some 20-
40% of the insulin-receptor binding was recovered
after insulin-Affigel affinity chromatography and elution
of the wheat-germ-agglutinin-agarose eluate.
Characterization of reconstituted receptors
The purified insulin receptor preparation was reconsti-
tuted into membrane vesicles by passage of a detergent-
soluble receptor/phospholipid mixture through Sepha-
dex G-50 to remove the detergents Triton X-100 and
sodium cholate. Insulin receptor binding and phospho-
lipid were eluted simultaneously in the void volume of
the column (Fig. la). Photon-correlation spectroscopy
indicated the presence of a uniform population of
phospholipid vesicles. Pearson V distribution-function
analysis of correlation coefficients resulted in poly-
dispersity factors of less than 0.3, indicating a highly
uniform vesicle population (Fig. lb) (McCally &
Bargeron, 1977). The best angle of measurement was
60-900, indicating that the vesicles behaved as spherical
particles. Vesicle size did not vary appreciably when
phospholipid composition was altered, except when high
concentrations of phosphatidylserine (33 %) were used.
Vesicles containing one-third phosphatidylserine by
weight had vesicle diameters approx. twice that observed
with all other vesicles in an experiment. The diameter of
all other vesicle preparations ranged in different experi-
ments from 32 to- 51 nm, but were constant for
reconstitutions performed within an experiment.
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Fig. 1. Elution profile of reconstituted insulin receptor and
proteoliposome size distribution
(a) A 500,1u portion of purified concentrated insulin
receptor (2-5 ,ug) was combined with 12 mg of
phospholipid (phophatidylcholine/phosphatidylethanol-
amine/phosphatidylserine, 1 1: 11:2, by wt.) containing a
final concentration of 2% sodium cholate. The mixture
was sonicated until clear and applied to the top of a
0.7 mm x 18 mm Sephadex G-50 column. The column was
eluted with 10 mM-Tris/100 mM-NaCl/2 mM-MgSO4,
pH 7.6 at 4 °C; 500,1 fractions were collected. Recon-
stituted insulin receptor was eluted as turbid fractions in
the void volume. *, A 280; x, 1251-insulin binding; A, [3H]-
phosphatidylcholine. (b) Vesicle diameter was deter-
mined in peak absorbing fractions by photon-correlation
spectroscopy in a Coulter model N4 Submicron Particle
Analyzer with size-distribution processor. Measurements
were made at 20 °C and at an angle of 60-90'. Viscosity
was taken as 1.005 cP. In the distribution illustrated, the
phospholipid composition was phosphatidylcholine/
phosphatidylethanolamine/phosphatidylserine (11:11:2,
by wt.). Mean diameter of the vesicles is calculated to be
36.7+ 12.7 nm.
The transmembrane orientation of the insulin receptor
was examined by testing the latency of receptor-catalysed
histone phosphorylation in intact reconstituted vesicles
compared with vesicles solubilized with 0.5% Triton X-
100 before the phosphorylation assay (Fig. 2). Insulin
receptors oriented right-side-out in the reconstituted
vesicles should have their insulin-binding domain
oriented outside the vesicles. If the insulin receptor
kinase is transmembrane to the binding site or sites
(Ulirich et al., 1985) and the reconstituted vesicles are
relatively impermeable to histone, then the rate of
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Fig. 2. Time course of phosphorylation of receptor p subunit and
histone catalysed by reconstituted vesicles treated with
and without Triton X-100
Insulin receptor reconstituted in phosphatidylcholine/
phosphatidylethanolamine/phosphatidylserine (11:11:2,
by wt.) was incubated at 22 °C with end-over-end mixing
in the absence or presence of 0.5% Triton X-100. Insulin
was added to both groups after 40 min (final concn.
100 nM); 30 min later, each tube was adjusted to 10 mM-
MgCl2, 3 mM-MnCl2, 0.3 mg of histone 2B/ml and 5 mm-
[y-32P]ATP (50,uCi). Final Triton X-100 concentration
was 0.4% in a final reaction volume of 100 /J. The
phosphorylation reaction was terminated at various times
by the rapid addition of 25 ,1 of 2.5 mg of y-globulin/ml
and 1 ml of 20% trichloroacetic acid. Samples were
vortex-mixed and stored at 4°C overnight. After pre-
cipitation the samples were centrifuged (27000 g for 5 min)
and washed once with diethyl ether/ethanol (1:1, v/v;
-20 °C). The samples were boiled in electrophoresis
sample buffer, electrophoresed on a 6-16 %-acrylamide
gradient gel, and the gel was stained with Coomassie Blue,
destained, dried and autoradiographed. (a) Phosphoryl-
ation of reconstituted insulin receptor and histone in
the absence or presence of 0.5% Triton X-100 at 10min
and 60 min incubation with [y-32PJATP. (b) Histone
phosphorylation at various times of vesicle incubation
with (0) or without (0) Triton X-100 was assessed by
scanning densitometry of the autoradiograph.
Insulin... - + - + - + - +
Fig. 3. Insulin receptors reconstituted into phosphatidylcholine/
phosphatidylethanolamine vesicles lack insulin-stimulated
kinase activity
Insulin receptor f subunit (90 kDa) at various stages of
purification was phosphorylated with 5 ,uM-[y-32P]ATP
(50,uCi/tube) in the absence (lanes a, c, e, g) or presence
(lanes b, d, f, h) of 100 nM-insulin for 30 min at 22 °C as
described in the Experimental section. Lanes (a) and (b),
20 #1 sample from 80 ml total volume of eluate from
wheat-germ-agarose affinity column. Lanes (c) and (d),
50 #1 sample from 15 ml total volume of elate from
insulin-Affigel affinity column. Lanes (e) and (f), 50 #1
sample of eluate from insulin-Affigel affinity column after
5.8-fold concentration on Amicon YM30 membranes.
Lanes (g) and (h), 50 1u sample from 0.5 ml total volume
of concentrated insulin receptor reconstituted into phos-
phatidylcholine/phosphatidylethanolamine (1:1, w/w)
vesicles. Lanes (a) and (b) are from an autoradiograph
exposed for 12 h. Lanes (cHh) were from an auto-
radiograph exposed for 2.5 h.
half that of the detergent-solubilized vesicles, suggesting
that the vesicular structure inhibits the ability of the
kinase to phosphorylate histone. The /B subunit of the
insulin receptor also exhibits latency of phosphorylation
in the intact vesicles (Fig. 2a). The latency of f-subunit
phosphorylation is probably due to the rate of ATP
diffusion to insulin receptor kinase oriented inside the
liposome. The latency of histone phosphorylation is
determined by the rate of diffusion of histone and ATP
into the liposome. Since histone is larger, its rate of
diffusion should be slower, accounting for the greater
latency ofphosphorylation relative to the insulin-receptor
f, subunit (Fig. 2a). Scatchard analysis of reconstituted
insulin receptor with or without Triton X-100 to
solubilize the vesicles yielded identical binding curves
(results not shown).
Phospholipid effects on reconstituted insulin receptor
kinase
Insulin-sensitive autophosphorylation of insulin recep-
tors is present throughout purification (Fig. 3). However,
reconstitution of kinase-active insulin receptor into
phosphatidylcholine/phosphatidylethanolamine vesicles
(1: 1, w/w) results in a loss ofinsulin-stimulated fl-subunit
autophosphorylation. The loss of sensitivity of reconsti-
tuted insulin receptor kinase to activation by insulin is
not due to sequestration of insulin-binding sites or the
inability of ATP to penetrate the vesicles (Fig. 2, and
results not shown). In fact, phosphorylation of the f,
subunit is observed in phosphatidylcholine/phos-
1987
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histone phosphorylation should be decreased in intact
vesicles relative to solubilized vesicles. Fig. 2(b) demons-
trates that intact vesicles containing insulin receptor
exhibit a rate of histone phosphorylation approximately
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taining equal amounts of phosphatidylc
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Phosphorylation was performed for 30 min as
the Experimental section. (a) Autoradiograp
receptor phosphorylated after reconstitutio
phatidylcholine/phosphatidylethanolamine
phosphatidylcholine/phosphatidylethanolami
containing 8.3 %Y,, 16.7%, or 33 %, phosphatid)
autoradiograph was scanned by densitomel
resulting peaks were cut out and weighed. TI
between control and insulin stimulation i
tidylcholine/phosphatidylethanolamine ves
phosphatidylcholine/phosphatidylethanolami
containing phosphatidylserine is illustrated in
values were 33.0, 34.2, 28.0 and 15.6mg for
16.74'/, and 33.3%', phosphatidylserine respect
phatidylethanolamine vesicles with or wit
insulin (Fig. 3). Taken together, the data
vesicles prepared in this study are leaky to sn
and allow both binding and receptor kinase
)___________ monitored. Insulin receptor reconstituted into vesicles
33.3 containing only phosphatidylcholine also lacked insulin-
nl I 1 stimulated fl-subunit autophosphorylation.
_ _ Preparation of vesicles containing receptor, phos-
phatidylcholine/phosphatidylethanolamine (1:1) and
phosphatidylinositol, phosphatidic acid or cholesterol
(8.3% of the total lipid by wt.) failed to restore insulin-
sensitivity to the reconstituted insulin receptor (results
not shown). The extent of receptor autophosphorylation
was not significantly changed by the inclusion of these
phospholipids.
* )ei- Inclusion of phosphatidylserine into phosphatidyl-
* choline/phosphatidylethanolamine vesicles restored
insulin-sensitivity to reconstituted insulin receptor when
the phosphatidylserine was added as either 8.3 % or
16.7% of the total lipid by wt. (Fig. 4). Whereas insulin
stimulated phosphorylation of the receptor f, subunit
by only 10% in phosphatidylcholine/phosphatidyl-
ethanolamine vesicles, the stimulation was 48 % and
66% in vesicles containing 8.3% and 16.7% phospha-
tidylserine respectively. Restoration of insulin-sensitivity
by phosphatidylserine was 40-50 % of the insulin
stimulation of soluble insulin receptor kinase. Although
phosphatidylserine conferred insulin-sensitivity to the
reconstituted insulin receptor kinase in all five experi-
ments performed, it elevated basal kinase activity in only
two of five experiments. Phosphorylation of insulin
receptor reconstituted into vesicles containing 33 %
phosphatidylserine (by wt.) showed markedly decreased
kinase activity and no insulin-sensitivity. Reconstituted
vesicles prepared with 33 % phosphatidylserine tended to
have twice the diameter (70-100 nM) of other prepara-
tions, and samples of the vesicles had lower receptor
content, as assessed by silver stain. This suggests that
vesicles containing 33% phosphatidylserine (by wt.) are
not suitable for reconstitution of insulin receptor.
0.2
m 0 -= H.p.l.c. tryptic-peptide mapping of the reconstituted
insulin receptor fi subunit
In order to determine whether changing the phospho-phosphartdyl- lipid environment affected phosphorylation of different
receptor esnaw or identical sites within the receptor , subunit, solubleinsulin receptor or insulin receptor reconstituted in
)somes con- phosphatidylcholine/phosphatidylethanolamine (1:1,
holine and w/w) or phosphatidylcholine/phosphatidylethanol-
amounts of amine/phosphatidylserine (11:11:2, by wt.) was
tnt at 12 mg. incubated with 5 ,iM-[y-32P]ATP of high specific radio-
described in activity (1 mCi/nmol). The tryptic phosphopeptides
th of insulin were resolved on a C-18 reverse-phase h.p.l.c. column
in in phos- with a linear propan-l-ol gradient (Yu & Czech, 1984).
vesicles or Analysis of the eluted peptides demonstrated no obvious
yserine. The differences in the phosphopeptide maps for each receptor
try and the preparation. No new peptide peaks were observed with
e difference receptor reconstitution into phosphatidylcholine/
n phospha- phosphatidylethanolamine or phosphatidylcholine/
nicles and phosphatidylethanolamine/phosphatidylserine vesicles.
ne vesicles Insulin receptor incorporated into phosphatidylcholine/
(b). Control phosphatidylethanolamine vesicles (Fig. 5b, 60 ng of
0'S,, 8.3'S insulin receptor) demonstrated the expected overall
tively, decrease in 32P labelling relative to insulin receptortively_____ incorporated into phosphatidylcholine/phosphatidyl-
ethanolamine/phosphatidylserine vesicles (Fig. Sc, 60 ng
hout 100 nm- of insulin receptor) in the presence of insulin. Some
indicate that 360 ng of soluble unreconstituted insulin receptor was
nall molecules labelled for the peptide map of Fig. 5(a), accounting for
activity to be the overall increase in 32P incorporated into soluble
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Soluble insulin receptors (a), or insulin receptors reconstituted into phosphatidylcholine/phosphatidylethanolamine (1:1, w/w)
vesicles (b) or phosphatidylcholine/phosphatidylethanolamine/phosphatidylserine (11:11:2, by wt.) vesicles (c) were
phosphorylated for 60 min at 22 °C with 5 ,pM-[y-32P]ATP (1 mCi) in the presence of 100 nM-insulin. The samples were washed,
reduced, alkylated and electrophoresed as described in the Experimental section. Gel pieces containing the phosphorylated
insulin receptor were washed and treated with trypsin (tosylphenylalanylchloromethane-treated) at 37 'C. The tryptic digests
were eluted from an h.p.l.c. reverse-phase C-18 column with a linear 0-40% propan-l-ol gradient. Radioactivity in each fraction
was determined by Cerenkov counting.
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Fig. 6. Insulin receptor reconstituted into phosphatidylcholine/
phosphatidylethanolamine vesicles demonstrate a pool of
high-affinity binding sites not observed with the inclusion
of phosphatidylserine into vesicles
A 50 ,ul sample of soluble insulin receptor (-), or insulin
receptor reconstituted into phosphatidylcholine/phospha-
tidylethanolamine (1: 1, w/w) vesicles (0), or phos-
phatidylcholine/phosphatidylethanolamine/phospha-
tidylserine ( 1: 11:2, by wt.) vesicles (0) were incubated
insulin receptor. The initial peak in each map was found
to contain only [32P]p1. Only phosphotyrosine was
observed in peak 1 (22-24 min) and peak 2 (40-41 min)
for each of the peptide maps in Fig. 5 (results not
shown). These peptide maps indicate that similar sites on
the insulin receptor were phosphorylated, regardless of
whether the receptor is phosphorylated in a soluble state
or when reconstituted into a lipid bilayer.
Reconstitution of insulin receptor into
phosphatidylcholine/phosphatidylethanolamine vesicles
increases high-affinity binding of insulin
In order to determine if the lack of insulin-sensitivity
of insulin receptor reconstituted into phosphatidyl-
choline/phosphatidylethanolamine vesicles was due to
an alteration of receptor affinity by the lipid environment,
we performed equilibrium-binding experiments and
analysed them by the method of Scatchard (1949) (Fig.
6). Reconstitution into phosphatidylcholine/phosphat-
idylethanolamine (1:1, w/w) vesicles resulted in a
marked increase in apparent affinity of insulin receptors
as compared with solubilized receptors (Kd= 0.12 nM
versus 0.76 nM respectively), and compared with insulin
receptor reconstituted into phosphatidycholine/phos-
phatidylethanolamine/phosphatidylserine (11:11:2, by
wt.) vesicles (Kd = 0.12 nM versus 0.44 nM respectively).
The affinity constants given in parentheses are estimates
with 0.05-22.3 nM-1251-insulin in the absence or the
presence of 100 nM-insulin. The experiment was performed
in duplicate with similar results.
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from linear regressions of the values from the higher-
affinity regions of the Scatchard plots.
DISCUSSION
The studies reported here demonstrate that highly
purified kinase-active insulin receptor can be reconsti-
tuted into vesicles of defined composition by combining
receptor protein with phospholipid and passing the
solubilized mixture over a molecular-sieving column to
remove excess detergent. Particle sizing indicates that the
vesicles are spherical in nature and have a uniform
distribution (Fig. lb). From experiments on the
phosphorylation of reconstituted insulin receptors in the
presence and absence of detergent, we have determined
that the insulin receptor kinase in the vesicle preparation
exhibits 5000 latency, indicating a 5000 right-side-out
orientation (Fig. 2). Scatchard analysis of vesicles in the
presence and absence of detergent indicated no difference
in the maximum number of binding sites. This contrasts
with the latency of phosphorylation observed with
reconstituted receptor, and indicated the vesicles are
leaky to small molecules such as insulin. Potential vesicle
leakiness makes strict assessment of receptor orientation
difficult, but does not impair the observations of
phospholipid effects on the insulin receptor kinase
activity. In fact, leakiness of the vesicles to ATP is
required in order to assess receptor kinase activity.
A major finding of these studies is the loss of insulin-
sensitive kinase activity in affinity-purified insulin recep-
tors which have been reconstituted into phospha-
tidylcholine/phosphatidylethanolamine vesicles (Fig. 3).
This is not due to inhibition of the kinase itself or to a
changed receptor orientation, because basal auto-
phosphorylation still occurs in such vesicles. Further-
more, the loss of responsiveness to insulin correlates with
an increase in the high-affinity binding of 1251-insulin to
reconstituted receptors (Fig. 6). The insensitivity of the
receptor kinase to insulin and the increase in high-affinity
binding are reversed by the inclusion of phospha-
tidylserine into receptor-containing phosphatidyl-
choline/phosphatidylethanolamine vesicles (Figs. 4 and
6). Addition of phosphatidylserine in the range
8.3-16.7% (by wt.) appears sufficient to restore insulin-
responsiveness to the reconstituted receptor. However,
the insulin-responsiveness is only 40-50 % of that seen in
the receptor before reconstitution. The loss of insulin-
sensitivity of the receptor reconstituted into phospha-
tidylcholine/phosphatidylethanolamine vesicles suggests
that a specific environment is required for maximal
hormone-responsiveness of the insulin receptor kinase.
All five experiments with insulin receptor reconstituted
into phosphatidylcholine/phosphatidylethanolamine/
phosphatidylserine vesicles demonstrated enhanced
kinase activity upon insulin addition. In two of those five
experiments, the basal kinase activity was less than the
basal activity in similar preparations made without
phosphatidylserine. Small differences in the elution
profile of different vesicle preparations, as well as small
differences in the amount of receptor incorporated, may
account for these differences. Nevertheless, we cannot
exclude completely the possibility that phosphatidyl-
serine has some negative effect on basal kinase activity as
well as a positive effect on the coupling of the hormone-
binding domain to the kinase.
Gould et al. (1982) reported that a saturated lipid
environment increased insulin receptor affinity relative to
an unsaturated environment. A change in saturation is
not likely to affect insulin receptor kinase activity or
binding activity in our present experiments, because the
small amounts of phosphatidylserine added to phospha-
tidylcholine/phosphatidylethanolamine vesicles in these
experiments should not significantly alter the overall
saturated/unsaturated fatty acid composition. A more
likely explanation for the effect of phosphatidylserine
on insulin-sensitive kinase activity and binding is the
effect of the phosphoserine head group on the re-
constituted receptor protein. Phosphatidylcholine and
phosphatidylethanolamine have a net charge of zero.
Phosphatidylserine, however, is negatively charged.
Phosphatidylserine has been shown to enhance prefer-
entially the incorporation of cytochrome oxidase into
lipid vesicles (Etyan & Racker, 1977). It is also known
that phosphatidylserine has a marked ability to enhance
the activity of reconstituted Na+/K+-ATPase. However,
the effect on Na+/K+-ATPase was not specific for
phosphatidylserine, as phosphatidylinositol and phos-
phatidylglycerol also had enhancing effects (Palatini
et al., 1977; Mandersloot et al., 1978; Roelofson & Van
Deenen, 1973). Ochoa et al. (1983) determined that
cholesterol and negatively charged lipids enhanced
agonist-stimulated ion flux of reconstituted acetylcholine
receptor, although a portion of these effects could be
ascribed to changes in vesicle size. In the present studies,
changing phospholipid content did not affect vesicle size.
Furthermore, the anionic phospholipids phosphatidyl-
inositol and phosphatidic acid as well as cholesterol
were ineffective in altering reconstituted insulin receptor
kinase activity in amounts equal to the amount of
phosphatidylserine used in these studies. Interestingly,
phosphatidylserine has been shown to be a potent
activator of protein kinase C (Nishizuka, 1984) and src
kinase (Ito et al., 1982), the latter also being activated by
other acidic phospholipids (Ito et al., 1982).
Phosphorylation of phosphatidylcholine/phospha-
tidylethanolamine vesicles containing insulin receptors in
the presence of insulin demonstrates a general loss of
32P in both phosphopeptide peaks after tryptic digestion,
compared with receptors in detergent solution (Fig. Sb).
Restoration of the insulin sensitivity by inclusion of
phosphatidylserine into receptor-containing phospha-
tidylcholine/phosphatidylethanolamine vesicles elevates
phosphorylation in both resolved phosphopeptide peaks
(Fig. Sc). No newly formed peaks are evident with the
addition of phosphatidylserine to vesicles, indicating
that the enhanced phosphorylation is not due to the
phosphorylation of previously unexposed sites.
The tryptic-peptide mapping system used here is
identical with that used by Yu & Czech (1984) to map the
immobilized phosphorylated insulin receptor. Phospho-
peptide peaks 1 and 2 in Fig. 5 appear identical with
peaks 2 and 3 in the peptide maps ofYu & Czech (1984).
Interestingly, the insulin receptor kinase is activated by
phosphorylation on the ,i subunit (Yu & Czech, 1984;
Rosen et al., 1983), and a tyrosine residue within peak 1 of
Fig. 5 [peak 2 of Yu & Czech (1984)] is believed to be
responsible for the activation. The addition of phospha-
tidylserine to reconstituted insulin receptor does not
significantly enhance the phosphorylation of peak 1 over
peak 2 (Fig. 5), suggesting that phosphatidylserine does
not alter the relative phosphorylation of the site that
activates the kinase. However, because each h.p.l.c. peak
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may contain more than one peptide, the change in
phosphorylation state of one peptide may be marked
relative to the total.
Interestingly, phosphorylation of a band that co-
migrates with the a subunit is prominent with insulin
receptors reconstituted into vesicles containing phospha-
tidylcholine and phosphatidylethanolamine, but is
not evident with soluble insulin receptors. If this
phosphorylated protein is indeed the a subunit, it may
reflect an intermolecular event, since deduction of the
insulin-receptor amino acid sequence (Ullrich et al.,
1985; Ebina et al., 1985) has indicated that the binding
domain within the a subunit and the kinase region within
the f subunit are on opposite sites of the lipid bilayer and
the a subunit resides completely above the lipid bilayer.
Thus, in our reconstituted system, phosphorylation of
the a subunit might occur if two receptors were inserted
within the bilayer with opposite orientations.
Reconstituted systems have been useful in a variety of
schemes to assess the function and interaction of various
membrane-associated proteins (Cerione et al., 1983,
1985; Radnay et al., 1985). Such reconstitution systems
may be useful in determining the relevance of the
tyrosine kinase activity endogenous to growth-factor
receptors. The observation that affinity-purified insulin
receptor can be inserted into an artificial lipid environ-
ment while still retaining insulin-sensitive kinase activity
makes possible investigations to study the functional
coupling of the insulin receptor with other cellular
proteins. Combination of purified components in lipo-
somes or in vivo by fusion of the purified insulin receptor
kinase with target cells holds promise as important
approaches to determining the role of tyrosine kinase
activity in insulin receptor function.
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